Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry

• প্রধান লেখক: Jun Young Lee (লেখক), Sung Hwa Kim (লেখক), Yeon Ho Park (লেখক), Jae Berm Park (লেখক), Su Hyung Lee (লেখক), Jaeseok Yang (লেখক), Myoung Soo Kim (লেখক), Deok Gie Kim (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: The Korean Society of Nephrology, 2022-09-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background Basiliximab (BSX) and antithymocyte globulins (ATGs), are two major immunosuppressive agents commonly used as induction therapy for kidney transplant (KT) recipients. The superiority of ATG over BSX has not been well established, especially in elderly KT recipients with low immunological...